AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17894651
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) and non-steroidal anti-inflammatory drugs (NSAIDs) exposure (low exposure category)
Trial: 9264481
Drug: Low-dose hirudin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hirudin (0.2 mg/kg bolus + 0.10 mg x kg(‐1) x h(‐1) infusion, n=271)
Trial: 17905357
Drug: GengNianAn (GNA)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GengNianAn (GNA) formula, taken twice daily for 12 weeks
Trial: 2659293
Drug: Gentamicin 80
RxNorm normalized name: gentamicin 80 mg/50 mL-0.9% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 80 mg i.m. twice daily
Trial: 10971309
Drug: Dofetilide 1500
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dofetilide 1500 microg, twice daily
Trial: 10971309
Drug: Dofetilide 1000
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dofetilide 1000 microg, three times daily
Trial: 15040643
Drug: Zidovudine 300
RxNorm normalized name: zidovudine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine 300 mg twice/day
Trial: 9729573
Drug: Caffeine ingestion
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine ingestion (6 mg/kg)
Trial: 19359073
Drug: L-arginine (14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (14 g/day)
Trial: 7682088
Drug: Late sequelae
RxNorm normalized name: Ferro-Sequels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late sequelae of chemotherapy
Trial: 7682088
Drug: Exploration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exploration of drug administration methods
Trial: 20430947
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amlodipine and valsartan
Trial: 26731258
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (to induce low or high postprandial glycemia)
Trial: 3542982
Drug: Rapid parenteral
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid parenteral injections of fluphenazine hydrochloride
Trial: 29485533
Drug: Intensive interdisciplinary
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive interdisciplinary pain treatment
Trial: 20927038
Drug: Raloxifene 60
RxNorm normalized name: raloxifene 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 60 mg/day
Trial: 12098564
Drug: Interferon-beta (IFN)
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-beta (IFN) 1b therapy
Trial: 6338768
Drug: Ocular decongestant
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ocular decongestant product 3 (naphazoline hydrochloride + antazoline phosphate or pheniramine maleate)
Trial: 17080004
Drug: 8 days
RxNorm normalized name: rotigotine
DrugBank: Rotigotine (DB05271)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8 days of antibiotics
Trial: 23681143
Drug: Perioperative IV
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative IV lidocaine (2 mg·kg·h)
Trial: 29345398
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (self-selected music using ear-bud headphones during the procedure)
Trial: 30685834
Drug: Subarachnoid anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subarachnoid anesthesia with ketamine 0.75 mg/kg (KE0.75)
Trial: 22869065
Drug: GHRH (tesamorelin)
RxNorm normalized name: GHRH(1-44)
DrugBank: Somatorelin (DB12656)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH (tesamorelin) 1 mg/d
Trial: 343968
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg fendosal
Trial: 12099782
Drug: Intravenous atropine
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous atropine or physostigmine
Trial: 207295
Drug: practolol injection
RxNorm normalized name: practolol
DrugBank: Practolol (DB01297)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: practolol injection (2 mg kg‐1 for 10 min); salbutamol infusion
Trial: 30239799
Drug: Anti-TNF-alpha therapy
RxNorm normalized name: anti-interleukin-1.alpha. immunoglobulin G rabbit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF-alpha therapy during pregnancy
Trial: 16613190
Drug: Thrombus aspiration
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombus aspiration therapy
Trial: 2486951
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid 500 mg every 8 hrs for 5 days
Trial: 1810523
Drug: Meclofenamic acid
RxNorm normalized name: Meclofenamic Acid
DrugBank: Meclofenamic acid (DB00939)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meclofenamic acid suppositories (200 mg) every 12 h during the immediate postsurgical period in gynecological patients.
Trial: 21110014
Drug: Rabeprazole (RPZ)
DrugBank: Rabeprazole (DB01129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rabeprazole (RPZ) 40 mg
Trial: 31641074
Drug: High-Flow Nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Flow Nasal Cannula (HFNC) therapy
Trial: 29390064
Drug: Clopidogrel or
RxNorm normalized name: clopidogrel Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel or Ticagrelor (randomized antiplatelet treatment)
Trial: 9194107
Drug: Intravenous ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ceftazidime plus tobramycin (CAZ/TM)
Trial: 9249084
Drug: AGL group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGL group (58 g amino acids + 60 g glycerol)
Trial: 19815265
Drug: Silodosin 8
RxNorm normalized name: silodosin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silodosin 8 mg once daily with breakfast (de novo treatment)
Trial: 21166852
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg/day
Trial: 28799226
Drug: Educational intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational intervention consisting of educational outreach visits with feedback on prescribing and the development of a working procedure on medication reviews (MRs). Follow-up duration was 9 months.
Trial: 31549770
Drug: Low-dose-rate brachytherapy
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose-rate brachytherapy
Trial: 8204943
Drug: Droloxifene 20
RxNorm normalized name: Droloxifene
DrugBank: Droloxifene (DB15641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droloxifene 20 mg/day
Trial: 8204943
Drug: Droloxifene 40
RxNorm normalized name: Droloxifene
DrugBank: Droloxifene (DB15641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droloxifene 40 mg/day
Trial: 7676701
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C bound to activated carbon particles (MMC-CH) 50 mg dispersed throughout the peritoneal cavity before surgical closure
Trial: 1361795
Drug: Intraperitoneal netilmicin
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal netilmicin and vancomycin (500 and 60-100 mg daily respectively)
Trial: 31781230
Drug: Succinate-based dietary
RxNorm normalized name: succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinate-based dietary supplement (SBDS; Amberen)
Trial: 7962781
Drug: Dodecyl trimethyl
RxNorm normalized name: dodecyl benzoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dodecyl trimethyl ammonium bromide (DTAB) 7.5% for 20 minutes daily for 8 days
Trial: 2137666
Drug: Sustained-release isradipine
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release isradipine administered once daily
Trial: 2137666
Drug: Immediate-release isradipine
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate-release isradipine administered twice daily
Trial: 7946177
Drug: Sustained-release isradipine
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release isradipine
Trial: 16267767
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment (n=105)
Trial: 16267767
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment (n=122)
Trial: 6577782
Drug: Gemfibrozil therapy
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil therapy
Trial: 26813298
Drug: Placebo (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (150 mL 0.9% NaCl)
Trial: 9632030
Drug: Fluoxetine 20-60
RxNorm normalized name: fluoxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20-60 mg plus group psychotherapy
Trial: 16109116
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) 100 mg/d
Trial: 21842274
Drug: rizatriptan 10
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rizatriptan 10 mg
Trial: 16100154
Drug: Silver Nitrate
RxNorm normalized name: Silver Nitrate
DrugBank: Silver (DB12965)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Silver Nitrate (20 mL 0.5%)
Trial: 16100154
Drug: Talc Slurry
RxNorm normalized name: Talc
DrugBank: Talc (DB09511)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Talc Slurry (5 g diluted to 50 mL with saline)
Trial: 24385407
Drug: Other antiplatelet
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antiplatelet drugs
Trial: 26836244
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone therapy (17β-estradiol combined with norethisterone acetate 0.05 mg + 5 mg/d) for 24 weeks
Trial: 3904805
Drug: Tigason at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tigason at half of the maximal dose tolerated during the clearing phase of the treatment
Trial: 10393137
Drug: High calcium
RxNorm normalized name: Nutritional Supplement Oral Liquid [ENSURE HIGH CALCIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calcium diet (1180 +/‐ 117 mg)
Trial: 2082308
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine 90 mg
Trial: 24500725
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection
Trial: 18027674
Drug: Classic method
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classic method combined with prunrllae oral solution (group B1)
Trial: 11329107
Drug: ACE therapy
RxNorm normalized name: Salicylic Acid 0.5 g in 100 mL TOPICAL LIQUID [KOCOSTAR FACE THERAPY ACNE TREATMENT CREAM TO PATCH]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE therapy
Trial: 28749175
Drug: Local anaesthesia
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anaesthesia to deltoid muscle level; 3‐5 ml
Trial: 8203857
Drug: Gram-positive prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gram-positive prophylaxis with 10(6) U of penicillin i.v. every 6 hours (or 750 mg of vancomycin i.v. q12h if penicillin allergic) in addition to standard antimicrobial prophylaxis.
Trial: 8559485
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (500 micrograms thrice weekly for 3 months, then 200 micrograms thrice weekly for the next 3 months)
Trial: 9666011
Drug: Fluconazole weekly
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole weekly (400 mg)
Trial: 19694342
Drug: Enteral diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral diet supplements with arginine and fiber (group I)
Trial: 12442604
Drug: Carbohydrate solution
RxNorm normalized name: phosphorated carbohydrate solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate solution (25 grams carbohydrates)
Trial: 25146061
Drug: Royal Jelly
RxNorm normalized name: ROYAL JELLY
DrugBank: Royal jelly (DB14250)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Royal Jelly (1000 mg capsule taken orally once daily for two consecutive menstrual cycles)
Trial: 30348101
Drug: Tirofiban treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban treatment
Trial: 15329426
Drug: Recombinant surfactant
RxNorm normalized name: Recombinant surfactant SP-D
DrugBank: Recombinant surfactant protein D (DB18438)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant surfactant protein C-based surfactant (up to four intratracheal doses within 24 hours)
Trial: 2611359
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of cyclosporine
Trial: 8727431
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume (VT) increased to 12-14 ml/kg for 30 min
Trial: 8727431
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume (VT) decreased to 6-8 ml/kg for 30 min
Trial: 7803885
Drug: Histamine2-receptor antagonists
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Histamine2-receptor antagonists
Trial: 26627641
Drug: gp100 peptide
RxNorm normalized name: Gp100:280-288(288V) peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gp100 peptide vaccine
Trial: 12743562
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy with a standardized latex extract
Trial: 17319251
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% plus tramadol 100 mg (Group 2)
Trial: 2076398
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg slow-release nifedipine
Trial: 26225993
Drug: MVM +
RxNorm normalized name: Multivitamin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVM + G
Trial: 10701032
Drug: Intravenous ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ondansetron 100 micrograms/kg at induction (Group 1)
Trial: 1589702
Drug: Antacid or
RxNorm normalized name: Uni-Antacid Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid or placebo medication
Trial: 17947301
Drug: Any treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any treatment strategy (without treatment adjustments)
Trial: 16456211
Drug: Educational interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational interventions promoting evidence-based supply of non-prescription medicines
Trial: 28808847
Drug: Hyoscine N-butyl
RxNorm normalized name: n-butyl acrylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine N-butyl bromide (20 mg, slow intravenous injection)
Trial: 12947054
Drug: Cisplatin 100
RxNorm normalized name: CISPLATIN 100MG/VIL (PF) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 100 mg/m2 day 1 plus gemcitabine 1,250 mg/m2 days 1 and 8, every 3 weeks for six cycles (CG)
Trial: 20372991
Drug: Azithromycin tablets
RxNorm normalized name: Azithromycin Tablets
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin tablets (fasted state)
Trial: 26932797
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori eradication regimen (pantoprazole 40 mg b.i.d., bismuth subcitrate 120 mg q.i.d., tetracycline 500 mg q.i.d., metronidazole 500 mg t.i.d. for 14 days)
Trial: 19581281
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment strategy with methotrexate (MTX)
Trial: 8942454
Drug: Clozapine at
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine at medium serum level range (200-300 ng/ml)
Trial: 9059063
Drug: Treatment period
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment period of 32 weeks vs 48 weeks.
Trial: 8458096
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose GH treatment (40 units/m2/week)
Trial: 9440907
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no GH treatment)
Trial: 6113352
Drug: Intravenous acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous acyclovir
Trial: 11966623
Drug: Reduced dose
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced dose (27 mg) of intravesical bacille Calmette-Guérin (BCG)
Trial: 7032642
Drug: Sperm-agglutinating antibodies
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sperm-agglutinating antibodies in serum
Trial: 15224162
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (1000 mg administered intravenously 5 min before surgery)
Trial: 3886209
Drug: AVP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AVP infusion
Trial: 11165880
Drug: Parenteral Nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral Nutrition (TPN)
Trial: 10322244
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg
Trial: 31097971
Drug: Tian Jiu
RxNorm normalized name: Tian Qi Root
DrugBank: Panax notoginseng root (DB14304)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tian Jiu (TJ) therapy
Trial: 19499846
Drug: rifaximin 1200
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rifaximin 1200 mg/day
Trial: 20633511
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline injections
Trial: 21285531
Drug: All vaccines
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All vaccines (including both adjuvanted and non-adjuvanted)
Trial: 29125901
Drug: Hydroxychloroquine (HCQ)
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (HCQ) 400 mg once a day
Trial: 31344386
Drug: Vehicle treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle treatment (control)
Trial: 29843492
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg daily clopidogrel or triple therapy with clopidogrel and cilostazol
Trial: 24711073
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg PHGG daily for 4 weeks
Trial: 16317669
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 1 g/day for three weeks
Trial: 16317669
Drug: Dexamethasone 12
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone 12 mg/day for 1 week and placebo during weeks 2 and 3